Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy

The genomic revolution has identified therapeutic targets for a plethora of diseases, creating a need to develop robust technologies for combination drug therapy. In the present work, we describe a self-assembled polymeric nanoparticle (NP) platform to target and control precisely the codelivery of...

Full description

Bibliographic Details
Main Authors: Kolishetti, Nagesh, Dhar, Shanta, Valencia, Pedro Miguel, Lin, Lucy Q., Karnik, Rohit, Lippard, Stephen J., Langer, Robert, Farokhzad, Omid C.
Other Authors: MIT-Harvard Center for Cancer Nanotechnology Excellence
Format: Article
Language:en_US
Published: National Academy of Sciences (U.S.) 2013
Online Access:http://hdl.handle.net/1721.1/78881
https://orcid.org/0000-0003-0588-9286
https://orcid.org/0000-0002-2693-4982
https://orcid.org/0000-0002-2640-3006
https://orcid.org/0000-0003-4255-0492

Internet

http://hdl.handle.net/1721.1/78881
https://orcid.org/0000-0003-0588-9286
https://orcid.org/0000-0002-2693-4982
https://orcid.org/0000-0002-2640-3006
https://orcid.org/0000-0003-4255-0492

Similar Items